Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models

…, KW Ward, JL Adams, WE Bondinell… - The Journal of …, 2001 - journals.aai.org
The anaphylatoxin C3a is a potent chemotactic peptide and inflammatory mediator released
during complement activation which binds to and activates a G-protein-coupled receptor. …

Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic

…, DP Alberts, PK Bhatnagar, WE Bondinell… - Journal of medicinal …, 2000 - ACS Publications
Introduction. The vitronectin receptor, also known as Rvβ3, is a member of the integrin family
of heterodimeric transmembrane glycoprotein complexes that function in cellular adhesion …

Orally active and potent inhibitors of γ-aminobutyric acid uptake

FE Ali, WE Bondinell, PA Dandridge… - Journal of medicinal …, 1985 - ACS Publications
3-Pyrrolidineacetic acid (la), certain piperidinecarboxylic acids—ie, 3-piperidinecarboxylic
acid (2a), 1, 2, 5, 6-tetrahydro-3-pyridinecarboxylic acid (3a), and cis-4-hydroxy-3-…

Chrysene and methylchrysenes: presence in tobacco smoke and carcinogenicity

SS Hecht, WE Bondinell… - Journal of the National …, 1974 - academic.oup.com
The 6 methylchrysene isomers, synthesized in greater than 99.9% purity via unambiguous
routes, and chrysene were tested for complete carcinogenicity and tumor-initiating activity on …

Conformational preferences in a benzodiazepine series of potent nonpeptide fibrinogen receptor antagonists

…, JF Callahan, JM Samanen, WE Bondinell… - Journal of medicinal …, 1999 - ACS Publications
Previously, we reported the direct design of highly potent nonpeptide 3-oxo-1,4-benzodiazepine
fibrinogen receptor antagonists from a constrained, RGD-containing cyclic semipeptide. …

Potent, selective, orally active 3-oxo-1, 4-benzodiazepine GPIIb/IIIa integrin antagonists

…, FE Ali, LS Barton, WE Bondinell… - Journal of medicinal …, 1996 - ACS Publications
The role of GPIIb/IIIa antagonists in the prevention of thrombosis has gained increasing
attention in recent years. 1, 2 Since chronic oral administration of GPIIb/IIIa antagonists could, in …

Carcinogenicity of methylchrysenes

D Hoffmann, WE Bondinell, EL Wynder - Science, 1974 - science.org
Methylchrysenes are present in tobacco smoke and are suspected to contribute to the
tumorigenicity of this inhalant. Chrysene and the six isomeric methylchrysenes were obtained in …

Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of a highly constrained cyclic RGD peptide

…, LS Barton, JW Bean, WE Bondinell… - Journal of the …, 1993 - ACS Publications
In the absence of structural data or good models for the receptor, success in mimicking natural
peptide ligands with potent non-peptides has been elusive, in part because of uncertain …

Enantiospecific synthesis of SB 214857, a potent, orally active, nonpeptide fibrinogen receptor antagonist

WH Miller, TW Ku, FE Ali, WE Bondinell, RR Calvo… - Tetrahedron letters, 1995 - Elsevier
Bondinell, Raul R. Calvo, Larry D. Davis, Karl F. … Hall, William F. Huffman, Richard M.
Keenan, Chet Kwon, Kenneth A. … CH,NH,, THF (70% from 9); e) Cbz-L-Asp-P-methyl ester …

Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonist

KW Ward, LM Azzarano, WE Bondinell… - Drug metabolism and …, 1999 - ASPET
Allometric scaling may be used in drug development to predict the pharmacokinetics of
xenobiotics in humans from animal data. Although allometry may be successful for compounds …